Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Correlates of SSRI Drug Response: Impact of Stress System Genes
DRKS00003480Phase 4Recruiting
- Sponsor
- University Hospital of Psychiatry and Psychotherapy Bern
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of escitalopram in major depressive disorder (MDD), major depressive episode (MDE) and recurrent depressive disorder (RDD), sponsored by University Hospital of Psychiatry and Psychotherapy Bern. Primary endpoints: Neural correlates of SSRI drug response and Impact of stress system genes on SSRI response. Started Jan 2012; status: recruiting.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)major depressive episode (MDE)recurrent depressive disorder (RDD)
Beyond the preview
Go deeper on DRKS00003480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003480.